课题基金 / 基金详情

Development of packaging cells for production of BAC-derived recombinant Epstein-Barr virus

Development of packaging cells for production of BAC-derived recombinant Epstein-Barr virus
开发用于生产 BAC 衍生重组 Epstein-Barr 病毒的包装细胞
批准号:
18590445
负责人:
KANDA Teru
金额:
$2.59万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

KANDA Teru的其他基金

相似基金

相关文献

中文摘要
翻译
细菌人工染色体(BAC)系统可用于大肠杆菌eb病毒(EBV)基因组工程。我们的目标是建立一个包装系统来生产从BAC克隆衍生的重组ebv。我们测试了两种携带EBV辅助病毒的细胞系作为包装细胞的有效性;(1)P3HR-1细胞(来源于人伯基特淋巴瘤细胞)和(2)B95-8细胞及其衍生物(来源于狨猴淋巴母细胞样细胞系)。然而,结果表明,我们无法避免辅助病毒DNA与BAC克隆DNA的重组。因此,为了获得纯粹的重组ebv,我们改变了策略,建立了一个不含辅助病毒的系统。为此,我们克隆了EBV B95-8株的全基因组,并将BAC克隆DNA导入人293细胞。这一策略使我们能够有效地建立重组病毒产生细胞。由此产生的重组ebv在转化b淋巴细胞的效率以及表达转基因的能力方面优于先前报道的293衍生的重组ebv。以上结果表明,B95-8株EBV BAC克隆与293细胞结合使用是制备高滴度纯重组EBV的有效途径。
英文摘要
Bacterial artificial chromosome (BAC) system is useful for engineering the genome of Epstein-Barr virus (EBV) genome in E. coll. We aimed to establish a packaging system to produce recombinant EBVs derived from the BAC clone. We tested two cell lines harboring helper viruses of EBV for their usefulness as packaging cells; (1)P3HR-1 cells (derived from human Burkitt's lymphoma cells) and (2)B95-8 cells and their derivatives (derived from marmoset lymphoblastoid cell lines). However, the results revealed that we could not avoid the recombination between the helper virus DNA and the BAC clone DNA. Therefore, in order to get pure recombinant EBVs, we switched our strategy to establish a system that is free from helper virus. For this purpose, we cloned the full length genome of B95-8 strain EBV, and introduced the BAC clone DNA into human 293 cells. This strategy enabled us to efficiently establish recombinant virus-producing cells. The resultant recombinant EBVs are superior to previously-reported 293-derived recombinant EBVs in their efficiency to transform B-lymphocyte as well as in their ability to express transgenes. These results demonstrate that the combinational usage of the BAC clone of B95-8 strain EBV and 293 cells is an efficient way to produce high-titer pure recombinant EBVs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epstein-Barr Virus (EBV)-encoded RNA 2 (EBER2) but not EBERlplays a critical role in EBV-induced B-cell growth transformation.
Epstein-Barr病毒(EBV)编码的RNA 2 (EBER2)而非EBER1在EBV诱导的B细胞生长转化中发挥关键作用。
DOI: --
发表时间: 2007
期刊: Journal of Virology 81(20)
影响因子: --
作者: [今西 健一, ほか, Teru Kanda, Yi Wu, Teru Kanda, Yi Wu]
通讯作者: Yi Wu
DOI: 10.1242/jcs.03434
发表时间: 2007-05-01
期刊: JOURNAL OF CELL SCIENCE
影响因子: 4
作者: [Kanda, Teru, Kamiya, Masato, Takada, Kenzo]
通讯作者: Takada, Kenzo
EBV潜伏感染複製起点配列内のリピート配列の多寡とBリンパ球トランスフォーメーション活性の関連
EBV潜伏感染复制起点序列中重复序列丰度与B淋巴细胞转化活性的关系
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [今西 健一, ほか, Teru Kanda, Yi Wu, Teru Kanda, Yi Wu, Yi Wu, Tern Kanda, 神田 輝, Teru Kanda, 神田 輝]
通讯作者: 神田 輝
「研究成果報告書概要(和文)」より
摘自《研究结果报告摘要(日文)》
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [Kawauchi, et. al., Nishimura et al., Dezawa et al., Yoshizawa et al., 星野 幹雄, 星野 幹雄]
通讯作者: 星野 幹雄
共 7 条
    Are there any highly oncogenic Epstein-Barr virus strains?
    Chromosome tethering mechanism of latently infected Epstein-Barr virus genome
    • 批准号:
      24590567
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      KANDA Teru
    • 依托单位:
    Mechanism of host chromosome binding of latently infected Epstein-Barr virus episomes
    • 批准号:
      21590523
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      KANDA Teru
    • 依托单位:
    Functional analysis of EBNA1 protein by using a recombinant EBV with gene replacement
    • 批准号:
      14570258
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.56万
    • 财政年份:
      2002
    • 负责人:
      KANDA Teru
    • 依托单位:
    海外基金